Sexual side effects of SSRI's

I thought through 50 years and two marriages, IT (sex) was just because I wasnt 16 anymore! Yes, antidepressants can cause long-lasting sexual side effects that persist even after patients discontinue treatment, though this appears to be a rare but significant phenomenon. This condition is termed post-SSRI sexual dysfunction (PSSD). A comprehensive review of PSSD found that prevalence estimates suggest persistent symptoms in up to 74% of affected cohorts beyond 6 months. The pathophysiology appears multifactorial, involving 5-HT1A receptor desensitization, neurosteroid depletion via 5α-reductase inhibition, and epigenetic silencing of dopaminergic reward circuits. Notably, no FDA-approved treatments currently exist, though off-label use of dopamine agonists and low-power laser therapy shows preliminary promise. Early case reports documented this phenomenon. One notable case involved a 26-year-old male who experienced genital anaesthesia during sertraline treatment and remained symptomatic despite medication discontinuation 6 years previously. This case was particularly significant because it represented the first published report of SSRI-induced sexual side effects persisting beyond SSRI discontinuation  A systematic review examining sexual dysfunction following SSRI discontinuation identified two retrospective interventional studies, six observational studies, and 11 case reports . While it was not possible to determine reliable prevalence estimates, the review concluded that the potential for continued sexual disturbances despite discontinuation could not be entirely ruled out. More recent research has attempted to quantify the risk. One study estimated the risk for PSSD at 1 in 216 patients (0.46%) treated with serotonergic antidepressants. Additionally, serotonergic antidepressants were associated with an increased risk for erectile dysfunction overall (adjusted odds ratio = 3.2)  The specific symptoms of PSSD are well-documented. Sexual dysfunctions include low libido, anorgasmia, genital anesthesia, and erectile dysfunction  Genital anesthesia appears to be a particularly important symptom, as it did not correlate with depression or anxiety but was independently associated with sexual dysfunction severity  A qualitative study exploring the lived experience of PSSD revealed that this condition affects far more than just sexual functioning. Participants discussed experiences of being dismissed by professionals, feeling emotionally numb, and experiencing significant losses  The majority of survey respondents rated the effect of PSSD on their quality of life as extremely negative (59%) or very negative (23%)  The condition is characterized by specific diagnostic criteria established in 2022, which distinguish PSSD from depressive relapse by specific somatic symptoms like genital numbness. Importantly, sexual dysfunction should be actively assessed at baseline, during treatment, and after treatment cessation, as post-SSRI sexual dysfunction should be considered in patients in whom sexual dysfunction was absent before starting antidepressants but develops during or soon after treatment and persists after remission from depression and drug discontinuation. Current evidence supports that while SSRI-induced sexual side effects are typically dose-dependent and reversible, they can very rarely persist after SSRI discontinuation, often preceded by genital anesthesia. The research and understanding of PSSD remain limited, but available data support the existence of this condition as a severe iatrogenic condition requiring heightened pharmacovigilance. Future research must prioritize biomarker identification and prospective trials for targeted neurosteroid therapies to address this otherwise neglected need for sexual well-being.